Optimal management of Barrett’s esophagus: pharmacologic, endoscopic, and surgical interventions

Figures & data

Figure 1 Management of patients with Barrett’s esophagus with neoplasia.³⁴

Note: *For high risk cases, ie, HGD from multiple levels, poorly differentiated tumor, invasion of lymphatics, blood vessels, or neural structures.
Abbreviations: EMR, endoscopic mucosal resection; GI, gastrointestinal; PPI, proton pump inhibitor; HGD, high-grade dysplasia; IMC, intramucosal carcinoma; SMI, submucosal invasion; LNM, lymph node metastasis.

ChennatJSKondaVJWaxmanIEndotherapy for Barrett’s esophagus: Which, how, when and who?Gastrointest Endosc Clin N Am201121111913321112502

 PubMedGoogle Scholar